Leukemia/Lymphoma
RSSArticles
-
Simultaneously Detected Endometrial and Ovarian Carcinomas: A Prospective Clinicopathologic Study
-
Special Feature: Maintaining Board Certification
-
Clinical Briefs in Primary Care Supplement
-
XRT to Prevent Local Breast Cancer Recurrence: A Little More is Better
-
Ascites, Neoadjuvant Chemotherapy, and Ovarian Cancer
-
Clinical Staging and Chemoradiation for Early Stage Hodgkin’s Disease
-
Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2
-
Pulmonary Nodule in Patients with Breast Cancer
Of 34 breast cancer patients with pulmonary nodules and no other evidence for metastatic disease, progression occurred in only 3 (of the 26) whose nodules were < 1 cm in diameter, compared with all 8 in whom the nodules were > 1 cm. -
Dasatinib for CML Blast Phase after Imatinib Failure
Options for CML blast phase after imatinib failure have been very limited. -
Risks of Androgen Suppression Therapy for Prostate Cancer: The Importance of Comorbidities
In a post hoc analysis of patients entered on a prostate cancer clinical trial, among those receiving androgen suppression therapy, those with higher levels of comorbidity were more likely to suffer adverse consequences, and this was particularly evident for those who had lower risk for prostate cancer specific mortality.